Los Angeles Capital Management LLC raised its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 17.6% in the second quarter, Holdings Channel reports. The fund owned 296,935 shares of the company’s stock after acquiring an additional 44,406 shares during the period. Los Angeles Capital Management LLC’s holdings in HCA Healthcare were worth $95,399,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the business. Norges Bank acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $694,985,000. Royal Bank of Canada boosted its position in shares of HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after buying an additional 1,183,890 shares during the period. Capital World Investors raised its position in HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after buying an additional 1,019,750 shares during the last quarter. Sanders Capital LLC boosted its position in HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after acquiring an additional 456,738 shares during the last quarter. Finally, Lee Danner & Bass Inc. bought a new stake in shares of HCA Healthcare in the second quarter worth $131,527,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
Analysts Set New Price Targets
HCA has been the topic of several analyst reports. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Morgan Stanley assumed coverage on HCA Healthcare in a research note on Tuesday. They issued an “equal weight” rating and a $427.00 price target for the company. Truist Financial increased their price objective on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Oppenheimer upped their target price on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $359.89.
Insiders Place Their Bets
In related news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. The sale was disclosed in a filing with the SEC, which is available through this link. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares in the company, valued at $3,436,623.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders sold 8,844 shares of company stock worth $3,185,932 over the last three months. Insiders own 1.60% of the company’s stock.
HCA Healthcare Stock Performance
Shares of HCA stock traded down $9.77 on Friday, hitting $387.98. The company’s stock had a trading volume of 2,248,803 shares, compared to its average volume of 1,129,325. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $403.05. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The stock’s 50 day moving average is $355.43 and its 200-day moving average is $335.92. The company has a market capitalization of $101.62 billion, a PE ratio of 19.34, a PEG ratio of 1.52 and a beta of 1.68.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the business earned $4.29 earnings per share. Equities research analysts expect that HCA Healthcare, Inc. will post 22.5 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.68%. HCA Healthcare’s dividend payout ratio is 13.16%.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Short Selling: How to Short a Stock
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- What Does Downgrade Mean in Investing?
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- 3 Tickers Leading a Meme Stock Revival
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.